NCT01675323View on ClinicalTrials.gov

Glutamate, Hyperarousal and Restless Legs Syndrome

CompletedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Restless Legs Syndrome
Trial Locations (2)

21224

Johns Hopkins Baview Medical, Baltimore

Johns Hopkins Bayview Medical Campus, Baltimore

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Johns Hopkins University

OTHER

NCT01675323 - Glutamate, Hyperarousal and Restless Legs Syndrome | Biotech Hunter | Biotech Hunter